Navigation Links
InterMune to Participate in Pulmonary-Allergy Drugs Advisory Committee Meeting on March 9, 2010
Date:2/1/2010

the disease tends to affect slightly more men than women.  There are no medicines approved in the United States or Europe for the treatment of IPF.

About InterMune

InterMune is a biotechnology company focused on the research, development and commercialization of innovative therapies in pulmonology and hepatology.  InterMune has an R&D portfolio addressing idiopathic pulmonary fibrosis (IPF) and hepatitis C virus (HCV) infections.  The pulmonology portfolio includes pirfenidone for which InterMune has completed a Phase 3 program in patients with IPF (CAPACITY) and a New Drug Application (NDA) has been accepted for Priority Review by the FDA.  The hepatology portfolio includes the HCV protease inhibitor compound RG7227 (ITMN-191) that entered Phase 2b in August 2009 and a second-generation HCV protease inhibitor research program.  For additional information about InterMune and its R&D pipeline, please visit www.intermune.com.

Forward-Looking Statements

This news release contains forward-looking statements within the meaning of section 21E of the Securities Exchange Act of 1934, as amended, which reflect InterMune's judgment and involve risks and uncertainties as of the date of this release, including without limitation the statements related to anticipated regulatory timelines and the likelihood of regulatory success. All forward-looking statements and other information included in this press release are based on information available to InterMune as of the date hereof, and InterMune assumes no obligation to update any such forward-looking statements or informatio
'/>"/>

SOURCE InterMune, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. InterMune Announces Approval of Clinical Trial Authorization for Phase 1b Trial of ITMN-191
2. InterMune Announces Start of Phase 1b Trial of ITMN-191
3. InterMune Announces Top-Line Results of Phase 1b Trial of ITMN-191 (R7227) and Provides Program Update
4. InterMune Provides Additional Information on ITMN-191 (R7227) MAD Study Results
5. InterMune Announces Progress on Pirfenidone in IPF
6. InterMune Announces Receipt of Fast Track Designation for Pirfenidone From FDA
7. InterMune Announces Start of 14-Day Triple Combination Study of ITMN-191 in Patients With Chronic Hepatitis C
8. Roche, InterMune and Pharmasset Announce Initiation of INFORM-1, the First Dual-Combination Clinical Trial with Oral Antivirals in Hepatitis C
9. InterMune to Report Top-Line Results of Triple Combination Study of ITMN-191 in January 2009
10. InterMune to Conduct Conference Call and Webcast to Discuss Results of Triple Combination Study of ITMN-191
11. InterMune to Announce Results of Phase 3 CAPACITY Program of Pirfenidone in IPF Tomorrow, February 3
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... , August 3, 2015 ... 2015 market research with 2020 forecasts as well ... healthcare and medical devices intelligence collection of its ... simulation market with 2020 forecasts spread across 164 ... with 170 tables and figures is now available ...
(Date:8/3/2015)... , Aug. 3, 2015 Par Pharmaceutical ... conference call on Friday, August 7, 2015 at 9:00 ... the second quarter ended June 30, 2015.  Par is ... to the public in its filings with the Securities ... available on its website by following the instructions at ...
(Date:8/3/2015)... Aug. 3, 2015 OmniSeq, LLC today ... to the OmniSeq SM Genomic Network.  Recently, ... Institute (RPCI) and announced it was making available ... physician-driven, collaborative approach to genomic diagnostics that provides ... Institute is a rapidly expanding, multidisciplinary cancer care ...
Breaking Medicine Technology:Medical Simulation Market to see 14% CAGR to 2019 2Medical Simulation Market to see 14% CAGR to 2019 3Medical Simulation Market to see 14% CAGR to 2019 4Medical Simulation Market to see 14% CAGR to 2019 5Medical Simulation Market to see 14% CAGR to 2019 6OmniSeq Adds Wilmot Cancer Institute to its Collaboration-Based Treatment Network 2OmniSeq Adds Wilmot Cancer Institute to its Collaboration-Based Treatment Network 3
... Jan. 10, 2011 CoreLab Partners, Inc , ... Inc and Medifacts International, has launched a new advanced ... are pleased to announce the release of our proprietary ... development continuum by offering sponsors advanced technologies and integrated ...
... Underwriters Laboratories (UL), a world ... release of a white paper that addresses the current ... equipment. The white paper, "Home Healthcare Equipment: An ... highlights the unique challenges for manufacturers with the U.S. ...
Cached Medicine Technology:CoreLab Partners Launches Advanced Imaging Application 2CoreLab Partners Launches Advanced Imaging Application 3UL White Paper Examines Key Implications of Growing Home Healthcare Industry 2
(Date:8/3/2015)... ... August 03, 2015 , ... ... notes that while an overwhelming number of Hispanics believe people can positively affect ... 70 percent of participants queried said making diet changes was important. Far fewer ...
(Date:8/3/2015)... Hollywood, FL (PRWEB) , ... ... ... internet’s most-visited bodybuilding and fitness site and the largest online retailer of ... Supplement Awards. BPI Sports is up for 11 awards in the following ...
(Date:8/3/2015)... ... August 03, 2015 , ... ... amputation , AUGUST 3, 2015 – Since winning a South by Southwest® (SXSW®) ... Impossible – an organization whose mission is to develop technology for the sake ...
(Date:8/3/2015)... ... 03, 2015 , ... The art of preparing and cooking food comes naturally ... a young age, Nasreen Zereshki was extremely eager to cook Persian cuisine. Now that ... from My Persian Kitchen with the world. , Since Americans tend to be undereducated ...
(Date:8/3/2015)... ... August 03, 2015 , ... AxoGen, Inc. (NASDAQ: AXGN), a leader ... present at the Wedbush Healthcare Conference on Wednesday, August 12, 2015 at 9:45am (ET) ... archived replay of the Company’s presentation may be accessed via the investor relations section ...
Breaking Medicine News(10 mins):Health News:Hispanics More Likely to Struggle with Misinformation About Diabetes 2Health News:Hispanics More Likely to Struggle with Misinformation About Diabetes 3Health News:Hispanics More Likely to Struggle with Misinformation About Diabetes 4Health News:BPI Sports is Nominated for 11 Different 2015 Bodybuilding.com Supplement Awards 2Health News:BPI Sports is Nominated for 11 Different 2015 Bodybuilding.com Supplement Awards 3Health News:Not Impossible Earns Top Awards for Technologies Benefiting Humanity 2Health News:Not Impossible Earns Top Awards for Technologies Benefiting Humanity 3Health News:Not Impossible Earns Top Awards for Technologies Benefiting Humanity 4Health News:Persian Cuisine: Colorful and Extremely Healthy 2Health News:AxoGen, Inc. to Present at the Wedbush Healthcare Conference 2
... SAO PAULO, Aug. 3 Medial Saude S/A,(BOVESPA: MEDI3) (MEDIAL SAUDE) announces the ... Earnings Conference Call, When: Friday, August 14, 2009 ... How: Live over the Internet -- Simply log on ... address above., Conference call dial-in phone numbers:, ...
... ... Leading Plastic Surgery Societies Reveals Surprising Answers , ... New York, NY and Arlington Heights, IL (Vocus) August 3, 2009 -- ... another person. That,s just one finding from a recent consumer survey conducted on the ...
... , HATBORO, Pa., August 3 ... a leading technology provider of enterprise mobility solutions for the ... new mobility offering for healthcare providers, the InfoLogix M24 mobile ... professionals to access critical patient information at the point-of-care. ...
... , , ... System-Sonoma County, which includes Santa Rosa Memorial Hospital, a ... 80-bed sister facility, Petaluma Valley Hospital, selected Aegis Health ... at local employers. The program includes an on-site employer ...
... Ariz. Aug. 1, 2009 An international scientific ... has received a $1 million grant to study skin ... was made to a team led by Dr. Jeffrey ... Team Lead among the Principal Investigators in the two-year ...
... , , , ... today that their wireless remote monitoring devices have been selected ... North Carolina communities. The $870,000 grant is the largest Phase ... Wellness Trust Fund Commission (HWTF), which utilizes North Carolina,s share ...
Cached Medicine News:Health News:How Do Our Attitudes About Beauty Change As We Age? 2Health News:How Do Our Attitudes About Beauty Change As We Age? 3Health News:How Do Our Attitudes About Beauty Change As We Age? 4Health News:New InfoLogix M24 Mobile Clinical Assistant Will Enable Hospitals to Access Electronic Medical Records (EMR) Directly at the Point of Care 2Health News:New InfoLogix M24 Mobile Clinical Assistant Will Enable Hospitals to Access Electronic Medical Records (EMR) Directly at the Point of Care 3Health News:St. Joseph Health System-Sonoma County Partners With Aegis Health Group to Bring Health-Management Program to Area Employers 2Health News:TGen-led team is 1 of 7 selected for $1 million skin-cancer grants 2Health News:TGen-led team is 1 of 7 selected for $1 million skin-cancer grants 3Health News:TGen-led team is 1 of 7 selected for $1 million skin-cancer grants 4Health News:IDEAL LIFE's Remote Monitoring System Benefits Rural North Carolina Communities 2Health News:IDEAL LIFE's Remote Monitoring System Benefits Rural North Carolina Communities 3
... Silver Wire Coil and helix provide ... buckling.,Unique Silver Wire Construction eliminates springback ... Tip is designed to provide a ... aesthetic result. ,Trimmable ends ...
... Prosthesis,The AMS DURA II ... of cobalt-chrome alloy strands ... gives patients what they ... positioning, cosmetic concealment and ...
... The AMS 650™ and 600M™ malleable ... many patientsespecially those with limited dexterity. These ... allows the patient to position them in ... make the penis rigid enough for sexual ...
... The AMS 700 Series is an advanced ... in the abdomen, a pump placed in the ... the corpora cavernosa. It closely simulates the look ... standard for innovative penile implant technology, the AMS ...
Medicine Products: